A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival

Juliane Bremer, Raimund Kottke, Pascal D. Johann, Katja von Hoff, Pierluigi Brazzola, Michael A. Grotzer, Marcel Kool, Elisabeth Rushing, Nicolas U. Gerber

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Here, we present a patient with high-grade neuroepithelial tumors with mutations in the BCL6 corepressor BCOR (HGNET-BCOR), a rare, highly malignant brain tumor with poor prognosis. The patient underwent gross total tumor resection (GTR), high-dose chemotherapy, and, after local relapse, GTR, proton radiation, and chemotherapy. After a 7.5 year-long complete remission, the tumor recurred locally, was treated by GTR, and responded to temozolomide treatment. In addition to an internal tandem duplication in BCOR common to the majority of HGNET-BCOR cases, molecular analysis revealed a second BCOR mutation in this tumor: a frame shift mutation. The combination of these mutations was associated with relatively low BCOR expression compared to other HGNET-BCOR cases.

Original languageEnglish
Article numbere28384
JournalPediatric Blood and Cancer
Volume67
Issue number7
DOIs
Publication statusPublished - 1 Jul 2020

Keywords

  • BCOR
  • brain tumor
  • HGNET-BCOR
  • high-grade neuroepithelial tumor

Fingerprint

Dive into the research topics of 'A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival'. Together they form a unique fingerprint.

Cite this